BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernandez K, Spielbauer KK, Rusheen A, Wang L, Baker TG, Eyles S, Cunningham LL. Lovastatin protects against cisplatin-induced hearing loss in mice. Hear Res 2020;389:107905. [PMID: 32062294 DOI: 10.1016/j.heares.2020.107905] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ramkumar V, Mukherjea D, Dhukhwa A, Rybak LP. Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity. Antioxidants (Basel) 2021;10:1919. [PMID: 34943021 DOI: 10.3390/antiox10121919] [Reference Citation Analysis]
2 Bielefeld EC, Gonzalez A, DeBacker JR. Changing the time intervals between cisplatin cycles alter its ototoxic side effect. Hear Res 2021;404:108204. [PMID: 33618164 DOI: 10.1016/j.heares.2021.108204] [Reference Citation Analysis]
3 Fernandez KA, Allen P, Campbell M, Page B, Townes T, Li CM, Cheng H, Garrett J, Mulquin M, Clements A, Mulford D, Ortiz C, Brewer C, Dubno JR, Newlands S, Schmitt NC, Cunningham LL. Atorvastatin is associated with reduced cisplatin-induced hearing loss. J Clin Invest 2021;131:142616. [PMID: 33393488 DOI: 10.1172/JCI142616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Kim SY, Lee CH, Min C, Yoo DM, Choi HG. Association between statin medication and hearing impairment in a national health screening cohort. Sci Rep 2021;11:14388. [PMID: 34257355 DOI: 10.1038/s41598-021-93916-z] [Reference Citation Analysis]
5 Kim SY, Wee JH, Min C, Yoo DM, Choi HG. Association Between Sudden Sensorineural Hearing Loss and History of Statin Use: A Nested Case-Control Study. Otolaryngol Head Neck Surg 2021;165:149-56. [PMID: 33231512 DOI: 10.1177/0194599820969630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ingersoll MA, Malloy EA, Caster LE, Holland EM, Xu Z, Zallocchi M, Currier D, Liu H, He DZZ, Min J, Chen T, Zuo J, Teitz T. BRAF inhibition protects against hearing loss in mice. Sci Adv 2020;6:eabd0561. [PMID: 33268358 DOI: 10.1126/sciadv.abd0561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Steyger PS. Mechanisms of Ototoxicity and Otoprotection. Otolaryngol Clin North Am 2021;54:1101-15. [PMID: 34774227 DOI: 10.1016/j.otc.2021.08.007] [Reference Citation Analysis]
8 Bourguillon RO, Stokes WA, Dorth J, Schmitt NC. Repurposing Statin Drugs to Decrease Toxicity and Improve Survival Outcomes in Head and Neck Cancer. OTO Open 2021;5:2473974X211065715. [PMID: 34917872 DOI: 10.1177/2473974X211065715] [Reference Citation Analysis]
9 Mukherjea D, Dhukhwa A, Sapra A, Bhandari P, Woolford K, Franke J, Ramkumar V, Rybak L. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity. Expert Opin Drug Metab Toxicol 2020;16:965-82. [PMID: 32757852 DOI: 10.1080/17425255.2020.1806235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lin N, Urata S, Cook R, Makishima T. Sex differences in the auditory functions of rodents. Hear Res 2021;:108271. [PMID: 34074560 DOI: 10.1016/j.heares.2021.108271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gersten BK, Fitzgerald TS, Fernandez KA, Cunningham LL. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents. J Assoc Res Otolaryngol 2020;21:303-21. [PMID: 32583132 DOI: 10.1007/s10162-020-00759-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]